Status:
COMPLETED
Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer
Lead Sponsor:
University of California, San Francisco
Conditions:
Advanced Malignant Solid Neoplasm
Locally Advanced Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial investigates whether a joint and integrative approach to cancer care using palliative care and psycho-oncology is possible, and if it's beneficial to patients with cancer that has spread to...
Detailed Description
PRIMARY OBJECTIVES: I. To develop and refine a joint Integrative Palliative Care/Psycho-oncology telehealth group medical visit (GMV) intervention based on feedback from an open pilot study with pati...
Eligibility Criteria
Inclusion
- Carry a diagnosis of an advanced solid tumor cancer (locally advanced or metastatic, i.e., stage III or IV cancer)
- Be age \>= 18 years
- Be able to speak and read English
- Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report)
- Be capable of independently utilizing an online platform for telehealth group medical visits in a private setting (assessed by participant self-report)
- Eastern Cooperative Oncology Group (ECOG) performance status =\< 2 (Karnofsky \>= 60%)
- Be able to understand a written informed consent document, and be willing to sign it
Exclusion
- Have a cognitive or psychiatric condition prohibiting study consent or participation determined by co-principal investigators (PIs) or referring provider
- Be too medically unstable (or expected to become so during the study period) to participate in a telehealth group medical visit determined by co-PIs or referring providers
- Does not have insurance coverage for telehealth group medical visits
- Have extensive hearing loss such that ability to participate in the study would be impaired as determined by co-PIs or referring provider
Key Trial Info
Start Date :
January 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04697524
Start Date
January 26 2021
End Date
May 31 2023
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143